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Purpose: While many studies investigate the cytoskeletal properties of the lens with respect to cataract development,
examinations of how these molecular structures interact are few. Myosin light chain kinase (MLCK),  actin,  and myosin
are present on the crystalline lenses of chickens. The purpose of this experiment was to determine whether contractile
proteins found on the lens play a role in the optical functions of the lens at rest, and during accommodation.
Methods: Eyes of 6-day old white Leghorn chicks (Gallus gallus domesticus) were enucleated, with the ciliary nerve
intact. One eye was treated with the MLCK inhibitor 1-(5-iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-diazepine
hydrochloride (ML-7) and the other eye with vehicle only. Three concentrations of ML-7 were used: 1 µM, 10 µM, and
100 µM. The back vertex focal lengths (BVFLs) were measured before, during, and after accommodation using an optical
laser scanning monitor (Scantox™). To further confirm ML-7 activity, western blotting was performed to detect whether
MLCK was inhibited.
Results: Western blots confirmed that MLCK was inhibited at all three ML-7 concentrations. Ten µM ML-7 treatments          
led to longer BVFLs at rest (p=0.0338), while 100 µM treatments led to opposite changes, resulting in shorter BVFLs
(p=0.0220). While 1 µM treatments did not lead to significant optical changes (p=0.4416), BVFLs were similar in pattern
to those of the 10 µM group. ML-7 had no effects on accommodative amplitudes (p=0.7848).
Conclusions: Inhibition of MLCK by ML-7 led to differential changes in BVFLs that presumably affected lenticular
integrity. No apparent effect on accommodative amplitudes was observed.
Accommodation in humans was first described by von
Helmholtz as a cascade of events involving ciliary muscle
contraction, reduction in the tension of the zonules connecting
the ciliary muscle and the lens, and finally, a change of the
lens shape so that its surfaces are more curved, resulting in a
higher refractive power [1]. The crux of this model is that the
lens  is  pliable,  and  as  such,  undergoes  mechanical  stress
during accommodation.
Motility  and  stress  of  a  cell  involve  cytoskeletal
components such as intermediate filaments, actin, myosin,
and adhesion proteins such as the cadherins. While many
studies investigate the cytoskeletal properties of the lens with
respect  to  cataract  development,  very  little  information
pertaining to how these molecular structures interact, or are
altered  during  accommodation,  exists.  Previous  studies
revealed a network of filamentous f-actin polygonal arrays
that are colocalized with myosin in the anterior epithelium of
the lens [2,3]. A similar arrangement of actin and myosin was
observed at the posterior surface on the capsule in chicken
lenses, along with other proteins, such as N-cadherin, myosin
light chain kinase (MLCK), and additional proteins that are
involved in contraction [4]. These findings may suggest that
lenticular forces could contribute to accommodation. Cellular
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movements are known to occur when there is a presence of
both actin and myosin; their interactions form the basis of a
molecular motor, and this motor is found in muscle tissue as
well as in non-muscle tissue.
The purpose of this study was to determine whether the
contractile proteins found on the lens play a role in the optical
functions of the lens at rest, and during accommodation. Since
MLCK is found in lenticular cells, an MLCK inhibitor, such
as  1-(5-iodonaphthalene-1-sulfonyl)-1H-hexahydro-1,4-
diazepine hydrochloride (ML-7), would be expected to disrupt
the cytoskeletal proteins on the lens, such as actin and myosin.
It is known that phosphorylation of MLCK leads to various
physiological  processes,  including  contraction  of  smooth
muscle,  fibroblast  contraction  as  well  as  cytoskeletal
modeling by (actin) stress fibers in nonmuscle cells [5,6].
Therefore, inhibiting MLCK on the lens would interfere with
the possible contraction that is taking place, resulting in a
change in accommodative amplitude.
METHODS
Eye dissections and lens treatments: White leghorn hatchling
chicks (Gallus gallus domesticus) were obtained from Maple
Leaf Poultry,  New  Hamburg,  Ontario, Canada  and  were  fed
ad  libitum  with  lights  on  a  14:10  light:dark  cycle.  Chicks
were   cared   for   in  accordance  with  the  guidelines  of  the
Canadian Council  on Animal Care;  their management  is  in
accordance  with  guidelines  established by  the Institute  for
Laboratory Animal Research.
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2759Chicks were sacrificed by decapitation when they were 6
days old. Heads were bisected along the sagittal plane. Eyes
were enucleated and the posterior globe was removed except
for a wedge containing the intact ciliary nerve and ganglion.
For optical function assessments, the sclera was removed as
close to the lens as possible without damaging the ciliary
muscle so that the lens could be viewed by the cameras located
in  the  Scantox™  In  Vitro  Lens  Assay  System  (XTOX
Scientific, Napean, ON). For the western blot procedure, the
vitreous was also removed before removal of the posterior
portion of the lens capsule. All dissections were performed in
oxygenated  (95%  oxygen,  5%  carbon  dioxide)  Tyrode’s
saline (TS: 134 mM NaCl, 3 mM KCl, 20.5 mM NaHCO3,
1 mM MgCl2, 3 mM CaCl2, in deionized water).
For all experiments, either the left or the right eye of each
pair was treated for 15 min with 1 µM ML-7 in 0.001% (v/v)
ethanol (EtOH) in TS, 10 µM ML-7 in 0.01% (v/v) EtOH in
TS or 100 µM ML-7 in 0.1% (v/v) EtOH in TS while the
fellow eyes of each pair was treated with the appropriate
concentration of vehicle (0.001% (v/v) EtOH in TS, 0.01%
(v/v) EtOH in TS or 0.1% (v/v) EtOH TS, respectively).
Measurements of lenticular optical function: Following either
ML-7  or  vehicle  treatment,  each  eye  was  pinned  to  a
Sylgard®  (Dow  Corning,  Midland,  MI)  washer,  with  the
cornea facing down. The eye was then placed into a glass
chamber  with  an  access  tube.  A  custom-made  suction
electrode, connected to a Grass S43 stimulator (Astro-Med,
Inc., Brossard, QC), was passed through the access tube before
plugging the rest of the small tube with petroleum jelly. The
chamber was filled with 20% (v/v) fetal bovine serum (PAA
Laboratories, Etobicoke, ON) in TS to visualize the refracted
beams. The ciliary nerve was suctioned into the electrode tip.
Lenses were scanned using the Scantox™ In Vitro Lens
Assay  System  (XTOX  Scientific)  as  previously  described
[7,8]. In brief, a low-powered helium laser passed through the
lenses at 0.131 mm intervals away from the optical axis and
the back vertex focal lengths (BVFLs), the distances from the
back vertex of the lens to where refracted beams cross the
optical  axis,  were  measured  using  the  Scantox™  system.
Scans were obtained before, during and after accommodation.
Accommodation of the intact eye was induced by electrical
stimulation of the ciliary nerve (30 Hz, 1–1.5 mA).
Statistical analysis of measurements of optical function: For
each scan, the three central BVFLs were removed because of
the presence of sutures, regions of optical disorder that can
over- or under-estimate back vertex focal lengths. For each
pair of eyes, the scan with the smallest number of beams was
the standard for all other scans for that chick. BVFLs were
converted  from  millimeters  into  dioptric  values  using  the
refractive index of water, n=1.33. Accommodative amplitude
was  calculated  as  the  difference  between  the  mean  pre-
stimulation and stimulation vergence values for each eye.
Optical quality of the lens was assessed using two parameters,
focal length variability, which increases the amount of scatter
due to optical degradation, and spherical aberration (SA),
which is a measure of the deviation of marginal rays from
those at the optical axis.
Mixed  model  repeated  measures  analysis  of  variance
(ANOVA)  tests  were  used  to  determine  changes  in  back
vertex focal lengths (BVFLs), focal length variability and
spherical  aberration  (SA)  as  a  function  of  inhibition
treatments  (ML-7  versus  vehicle),  dosage  groups  (1  µM,
10  µM,  and  100  µM)  and  accommodative  state  (pre-
stimulation,  stimulation  and  post-stimulation).  Changes
associated with accommodative amplitude were also assessed
using a mixed model repeated measures ANOVA as a function
of inhibition treatments and dosage group. One-way repeated
measures  ANOVAs  with  Bonferroni-corrected  multiple
comparison  tests  were  used  as  post-hoc  tests  for  further
analysis of interactions between dependent or repeated data.
Greenhouse-Geisser correction factors were used for epsilon
<0.75. Results were significant at p≤0.05.
Western blot analysis: Western blots of the relative amounts
of phosphorylated myosin in the presence of ML-7 and its
vehicle (ethanol; EtOH) were used to confirm that ML-7 had
an inhibitory effect on myosin light chain kinase activity. The
posterior capsule of the lenses was removed then placed in
cold  20  µl  of  Phosphate-Buffered  Saline  (PBS:  137 mM,
NaCl, 3 mM  KCl, 101 mM  Na2HPO4, 2 mM KH2PO4, in
deionized  water).  Capsule  samples  were  then  centrifuged
(3,786× g for 10 min at 4 °C) and the supernatant collected.
The total protein concentration of each sample was quantified
using the BioRad DC protein assay™ (500–0111; BioRad
Laboratories, Mississauga, ON). Capsule samples were mixed
with  Biostab  (62513;  Biomol,  Hamburg,  Germany),  a
biomolecular storage solution (5:1 ratio, respectively) before
storing at –80 °C.
Capsule samples were diluted with gel loading buffer
(GLB: 100 mM Tris base [pH 7.4], 5% [v/v] glycerol, 2.5%
[v/v] SDS, 0.03% [w/v] bromophenol blue, in water) then
heated (3 min at 95 °C). For each western blot, samples (1 µl)
were run at the same concentrations to ensure equal loading
of  protein.  Concentrations  below  1  µg/µl  were  not  used.
Samples were loaded on a polyacrylamide gel (PhastGel™,
gradient 10–15, 57–6781–00; GE Healthcare Bio-Sciences,
Mississauga, ON) and run on a GE Phastsytem™ Separation
& Control Unit (GE Healthcare, Uppsala, Sweden, at 250 V,
15 °C, 30 min) with SDS Buffer strips (17–0515–01; GE
Healthcare Bio-Sciences). Proteins were electro-transferred
onto  wet  immuno-blot  polyvinylidene-difluoride  (PVDF)
membranes  (162–0176;  BioRad  Laboratories)  and
membranes were dried (RT, 15 min followed by 50 °C at 45
min).
Membranes were blocked (blocking buffer [BB]: 8% [w/
v] skim milk powder in 0.5% [v/v] Tween-20 in PBS [PBS-
T], 45 min) then washed in PBS-T (5 min) before submerging
Molecular Vision 2011; 17:2759-2764 <http://www.molvis.org/molvis/v17/a298> © 2011 Molecular Vision
2760in  anti-phospho-myosin  (M6068;  Sigma,  St.  Louis,  MO;
1:1000 in 90% PBS-T: 10% BB, 4 °C overnight). Membranes
were  then  washed  (4×5  min,  PBS-T)  and  anti-phospho-
myosin was labeled with horseradish peroxidase-conjugated
goat  anti-rabbit  IgG  solution  (H  &  L,  ab6721;  Abcam,
Cambridge, MA; 1:1000 in 90% PBS-T: 10% BB; 1 h, RT).
Membranes were washed (3×5 min, PBS-T) followed by a
final  wash  (PBS,  1  min).  Proteins  were  visualized  with
chemiluminescent ECL™ detection (RPN2132, RPN2133;
Amersham Biosciences, Mississauga, ON) and imaged using
the  Storm  840™  imaging  system  (Molecular  Dynamics,
Sunnyvale,  CA).  Protein  expression  was  measured  by
quantifying  the  amount  of  fluorescence  using  the
ImageQuant™ software.
RESULTS
Measurements of optical functions of the lens: As expected,
differences in the mean back vertex focal lengths (BVFLs)
were detected as a function of accommodative state, with
BVFLs during accommodation shorter than those at rest for
all three dosage groups (p<0.0001; Figure 1). ML-7 at all
doses inhibited MLCK activity, as shown by the relatively
lower amounts of phosphorylated myosin in western blots of
the lenticular posterior capsules treated (intensity relative to
respective vehicle: 1 µM 50.7%; 10 µM 47.2%; 100 µM:
16.7%; Figure 1: insets), but did not have an overall (main)
effect on BVFLs (Figure 1). However, interaction between
dosage  group  and  inhibition  treatments  was  detected
(p=0.0138), indicating that ML-7 had differential effects on
BVFLs. Post-hoc tests indicated that both the 10 µM and
100 µM ML-7 treatments had effects on BVFLs (p=0.0338
and p=0.0220, respectively) that were opposite. For the 10 µM
group, BVFLs of ML-7-treated eyes were significantly longer
than those for vehicle-treated eyes during the two resting
states  (Figure  1B;  pre-accommodation  mean±s.d.:
20.10±1.65  mm  versus  19.28±1.48  mm,  respectively,
p=0.0027;  post-accommodation:  20.02±1.57  mm  versus
19.10±1.29 mm, p=0.0015), but not during accommodation
(15.61±1.18 mm versus 15.23±1.02 mm, p=0.6477; Figure
1B). While differences in mean BVFLs for the 1 µM group
were not significant (Figure 1A; p=0.4416), BVFLs were
similar in pattern to those of the 10 µM group, with ML-7-
treated  eyes  showing  slightly,  although  not  significantly
longer BVFLs than their fellow vehicle-treated eyes (pre-
accommodation:  20.22±1.44  mm  versus  19.94±0.85  mm,
respectively,  p=1.000;  accommodation:  15.98±1.00  mm
versus  15.19±1.35  mm,  p=0.4623;  post-accommodation:
20.11±1.35  mm  versus  19.54±1.11  mm,  p=1.000,
respectively;  Bonferroni;  Figure  1A).  ML-7  treatment
(100 µM) resulted in the opposite trend to the two lower doses,
with ML-7-treated eyes showing shorter BVFLs compared to
their fellow control eyes (Figure 1C; pre-accommodation:
19.22±1.64  mm  versus  19.85±1.90  mm,  p=0.0132;
accommodation:  14.83±1.34  mm  versus  15.54±1.65  mm,
p=0.0082;  post-accommodation:  19.02±1.66  mm  versus
19.54±1.66 mm, p=0.0615).
Figure  1.  Effects  of  ML-7  on  mean  back  vertex  focal  lengths
(±s.e.m). Line graphs show the effects of lenses treated with ML-7
(filled symbols) and vehicle (empty symbols) pre-, during, and post-
accommodation. A: 1 µM (n=4), B; 10 µM (n=12), C: 100 µM (n=9).
For all three dosage groups, focal lengths for the accommodation
state were significantly shorter than those at rest (p<0.0001; denoted
by  asterisks).  Daggers  denote  significant  differences  in  BVFLs
between ML-7- and vehicle-treated eyes at the same functional state.
Insets: western blots showing relative amounts of phosphorylated
myosin for all dosage groups. Please refer to the text for relative
intensity values.
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ML-7-induced differences in BVFLs were detected for pre-
stimulation states for the 10 µM and 100 µM ML-7 treatment
groups, accommodative amplitudes were not different across
dosage groups (p=0.7848), inhibition treatments (p=0.6112),
nor was any interaction detected between these two factors
(p=0.0646; Figure 2).
DISCUSSION
Effects  of  ML-7  on  lenticular  optics:  This  study  was
performed to determine whether contractile microfilaments
could affect the optics or accommodative amplitudes of the
lens. The data indicated that ML-7 has effects on the optics of
the lens, resulting in longer mean BVFLs for lower doses of
ML-7 in eyes at rest. The lower BVFLs indicate a change in
the shape of the lens, presumably a flattening, which could
arise as a result of a loss of tone or stiffness of the lens or of
the ciliary muscles that surround and directly articulate the
lens. Ciliary muscle in chicks is skeletal in nature and is
therefore  likely  unaffected  by  ML-7;  since  ML-7
preferentially  inhibits  smooth  muscle  MLCK  (smMLCK)
[9-11], and given that smMLCK expression is lower than that
of skeletal MLCK in skeletal muscles [12], we speculate that
ML-7 effects on ciliary muscle, if any, would be negligible.
Moreover, unpublished data from our laboratory indicate that
isolated  chicken  lenses  exposed  to  low  concentrations  of
ML-7 become softer (as assessed by lower amounts of force
exerted by the lens upon being compressed between two metal
plates in solution; data not shown), which, together with the
observations  that  ML-7  had  no  effect  on  accommodative
amplitudes from contraction of the ciliary muscles (Figure 2),
suggest that ML-7 acted directly via changes to lenticular
integrity and consequently, lenticular shape, rather than via
Figure 2. Effects of ML-7 on accommodative amplitudes (±s.e.m).
Bar graphs show the accommodative amplitudes of 1 µM (n=4),
10 µM (n=12), and 100 µM (n=9) ML-7-treated (filled bars) and
vehicle-treated (empty bars) eyes, respectively.
the ciliary muscle. Our western blots of the posterior lens
capsule confirming that ML-7 treatments were effective in
reducing the phosphorylation of myosin (Figure 1, insets)
would  seem  to  further  support  a  role  for  the  lens,  and
moreover, that loss of stiffnes was a result of ML-7-induced
inhibition of MLCK and its subsequent effects on myosin and
actin  at  the  lens  capsule.  Although  we  did  not  carry  out
experiments  to  confirm  whether  myosin  and  actin
distributions  in  the  lenses  were  altered  with  ML-7,  other
investigators have shown that ML-7 reduces the stiffness of
nonmuscle cells such as fibroblasts [13], and induces loss of,
or prevents formation of actin stress fiber bundles in human
carcinoma [14], fibroblast [14-16] and endothelial cells [17,
18].  A  study  by  Collin  and  colleagues  [19]  showing  that
relaxation  of  baby  hamster  kidney  cell  podosomes  is
associated with the disappearance of actin stress fibers adds
support to our findings that ML-7-induced loss of stiffness is
almost certainly related to loss of actin stress fiber formation.
The possibility that changes in BVFLs were a result of
changes  to  the  refractive  index  of  the  lens  must  also  be
acknowledged. Presumably, for such a decrease in refractive
index to occur, and within the time span observed, ML-7
would have to directly affect the crystallin proteins. However,
we  do  not  believe  that  this  could  occur  without  causing
changes to the optical quality of the lenses and both the focal
length variability and the negative spherical aberrations that
are typical of avian lenses were observed in our experiments
to be unaffected by ML-7 (data not shown). We know of no
mechanism for ML-7 to affect the down-regulation of the
crystallin proteins.
That treatment of 100 µM ML-7 results in the opposite
response,  i.e.,  shorter,  rather  than  longer  BVFLs,  would
suggest that the cytoskeletal integrity and stiffness of the
lenses were also opposite to lenses treated with lower doses
of ML-7. Cytoskeletal distributions were not examined in this
study but preliminary results of a parallel study by our group
indicate that a 100 µM dose of ML-7 leads to stiffer (isolated)
chick lenses [20]. A dual or biphasic response for ML-7 in
other  nonmuscle  cells  was  reported  by  Takizawa  and
colleagues [14], who showed that cell-spreading behaviors
were  opposite  depending  on  the  the  dose  of  ML-7.  That
BVFLs  of  lenses  were  diametrical  in  our  study  might  be
related to the specificity of ML-7 and its mode of inhibition.
At higher doses, ML-7 inhibits kinases other than MLCK,
such as protein kinase A (PKA) and protein kinase C (PKC;
Ki values of 21 µM and 42 µM, respectively; [21]). Of the two
kinases, PKA is the likelier candidate as an enzyme whose
inhibition  could  lead  to  opposite  effects  on  cytoskeletal
integrity and therefore by inference, on the stiffness of the lens
and BVFLs. Microinjection of PKA into living fibroblast cells
leads to PKA-induced dephosphorylation of MLCK and actin
filament disassembly [22], while inhibition of PKA activity
in endothelial cells results in the opposite, i.e., actin stress
fiber  formation  [23].  However,  a  role  for  PKA  remains
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stronger than those of MLCK inhibition, which is not known.
It should also be noted that opposing behaviors may not be
related to secondary inhibition effects of ML-7, but rather to
other  regulatory  proteins  that  differentially  mediate  the
sensitivities of the cytoskeletal components to ML-7 [14].
As observed in previous experiments [7,8], optical scans
for all lenses showed negative spherical aberrations (SAs),
which increased with accommodation (p=0.0194; data not
shown),  although  no  changes  in  SA  were  detected  as  a
function  of  ML-7  treatment  (p=0.1933;  data  not  shown).
These results suggest ML-7 effects were similar across the
entire anterior and posterior surfaces of the lens; observations
that BVFLs were longer with ML-7 are also consistent with
the idea of a global effect of ML-7 on the lens.
Effect of ML-7 on accommodation: Unlike a previous study,
which showed that different resting state BVFLs could have
effects  on  accommodative  amplitudes  [7],  no  changes  in
accommodative  amplitudes  were  observed  with  ML-7
treatment (Figure 2), despite ML-7-dependent differences in
resting  state  BVFLs  (Figure  1).  Differences  in  the
accommodative amplitudes arising from changes in lenticular
integrity may have been too subtle to detect. Alternatively,
contributions  by  the  lens  may  have  been  masked  by  the
contractile forces applied by the ciliary muscle; ciliary muscle
had about a 10-fold larger contractile force across all groups
(~20 D, Figure 2) compared to the equivalent change in power
between ML-7-treated and vehicle-treated eyes at rest (~2 D,
calculated from BVFL vergences, calculation not shown).
In summary, inhibition of MLCK led to changes in the
optics of the lens, resulting in a change in BVFL, and therefore
presumably,  to  lenticular  shape  and  integrity.  However,
putative  integrity  changes  were  not  reflected  in  the
accommodative amplitudes observed, which may have been
a consequence of masking effects by larger ciliary muscle
contractions. Thus, we could not unequivocally rule out a role
for  contractile  proteins  in  accommodation.  A  preliminary
study is planned to determine whether lenticular integrity
changes arising from alterations to cytoskeletal proteins can
affect accommodation.
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